Thrombosis
From the Journals
‘Cautious’ DOAC underdosing in AFib may push mortality higher
Risk-averse clinicians might be doing more harm than good by prescribing direct oral anticoagulants at lower-than-recommended dosages in hope of...
Conference Coverage
COVID-19 and Blood Clots: Inside the Battle to Save Patients
Protocols are now in place to prevent thrombosis, hematologist-oncologist tells colleagues at AVAHO Virtual Meeting.
From the Journals
Lusutrombopag found safe, effective for severe thrombocytopenia in patients with hepatocellular carcinoma
Lusutrombopag met the primary efficacy endpoint and did not significantly increase the rate of postprocedural thromboses, compared with placebo....
Conference Coverage
HOME-PE trial clarifies which pulmonary embolism patients to treat at home
“Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides
From the Journals
Aspirin may accelerate cancer progression in older adults
Clinical Insights
Hematologic manifestations of COVID-19
From the Journals
Low-dose prasugrel preserves efficacy but lowers bleeding in elderly
In an ISAR-REACT 5 substudy of elderly ACS patients, low-dose prasugrel was favored over ticagrelor.
From the Journals
New oral anticoagulants drive ACC consensus on bleeding
A new consensus document from the American College of Cardiology updates management of acute bleeding in patients on oral anticoagulants.
From the Journals
PCI or not, mortality climbs with post-ACS bleeding complications
Prevention of bleeding after ACS, whether managed medically or with PCI, should get as much attention as prevention of later ischemic events.
Conference Coverage
Chewed prasugrel for primary PCI? Forget it!
Tirofiban tops cangrelor for platelet inhibition in ST-elevation MI.
Clinical Insights
Endothelial injury may play a major role in COVID-19–associated coagulopathy